Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 239 of the 239 references it cites were found in a registry or an index.

Wnt/β-catenin-driven EMT regulation in human cancers

Open access
Xue, Wenhua, Yang, Lin, Chen, Chengxin, Ashrafizadeh, Milad, Tian, Yu, Sun, Ranran · 2024 · Cellular and Molecular Life Sciences

Abstract

Metastasis accounts for 90% of cancer-related deaths among the patients. The transformation of epithelial cells into mesenchymal cells with molecular alterations can occur during epithelial–mesenchymal transition (EMT). The EMT mechanism accelerates the cancer metastasis and drug resistance ability in human cancers. Among the different regulators of EMT, Wnt/β-catenin axis has been emerged as a versatile modulator. Wnt is in active form in physiological condition due to the function of GSK-3β that destructs β-catenin, while ligand–receptor interaction impairs GSK-3β function to increase β-catenin stability and promote its nuclear transfer. Regarding the oncogenic function of Wnt/β-catenin, its upregulation occurs in human cancers and it can accelerate EMT-mediated metastasis and drug resistance. The stimulation of Wnt by binding Wnt ligands into Frizzled receptors can enhance β-catenin accumulation in cytoplasm that stimulates EMT and related genes upon nuclear translocation. Wnt/β-catenin/EMT axis has been implicated in augmenting metastasis of both solid and hematological tumors. The Wnt/EMT-mediated cancer metastasis promotes the malignant behavior of tumor cells, causing therapy resistance. The Wnt/β-catenin/EMT axis can be modulated by upstream mediators in which non-coding RNAs are main regulators. Moreover, pharmacological intervention, mainly using phytochemicals, suppresses Wnt/EMT axis in metastasis suppression. Graphical abstract

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00018-023-05099-7

Cites

239 of 239 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The presence of Wnt ligand mediates the function of Frizzled and LRP5/6 receptors to suppress GSK-3β, Dishevelled, CK1α and Axin. Then, it enhances the intracellular accumulation of β-catenin to transfer into nucleus and enhance gene transcription. However, lack of Wnt ligand mediates the phosphorylation of β-catenin to enhance its proteasomal degradation
Fig. 1 The presence of Wnt ligand mediates the function of Frizzled and LRP5/6 receptors to suppress GSK-3β, Dishevelled, CK1α and Axin. Then, it enhances the intracellular accumulation of β-catenin to transfer into nucleus and enhance gene transcription. However, lack of Wnt ligand mediates the phosphorylation of β-catenin to enhance its proteasomal degradationCC BY · PubMed Central
Fig. 2 The aberrant levels of Wnt can cause progression of both solid and hematological tumors. Wnt interacts with ZEB and other EMT-TFs to mediate EMT. In each cancer, a number of related molecular interaction regulating Wnt/EMT axis have been identified
Fig. 2 The aberrant levels of Wnt can cause progression of both solid and hematological tumors. Wnt interacts with ZEB and other EMT-TFs to mediate EMT. In each cancer, a number of related molecular interaction regulating Wnt/EMT axis have been identifiedCC BY · PubMed Central
Fig. 3 Wnt/EMT axis in cancer drug resistance. The nuclear transfer of β-catenin enhances N-cadherin and vimentin levels, while it downregulates E-cadherin to mediate EMT in cancer metastasis. Moreover, β-catenin can be upregulated by β-arrestin and METTL1 to mediate EMT and drug resistance
Fig. 3 Wnt/EMT axis in cancer drug resistance. The nuclear transfer of β-catenin enhances N-cadherin and vimentin levels, while it downregulates E-cadherin to mediate EMT in cancer metastasis. Moreover, β-catenin can be upregulated by β-arrestin and METTL1 to mediate EMT and drug resistanceCC BY · PubMed Central
Fig. 4 The role of Wnt/EMT in cancer drug resistance and its suppression by anti-cancer drugs. The application of oncolytic adenovirus allows to suppress the Wnt/EMT axis for reversing gemcitabine resistance. When Wnt expression increases, it stimulates Twist/EMT axis in mediating drug resistance. Moreover, suppression of Wnt by thymoquinone and other compounds can prevent cancer metastasis and chemoresistance
Fig. 4 The role of Wnt/EMT in cancer drug resistance and its suppression by anti-cancer drugs. The application of oncolytic adenovirus allows to suppress the Wnt/EMT axis for reversing gemcitabine resistance. When Wnt expression increases, it stimulates Twist/EMT axis in mediating drug resistance. Moreover, suppression of Wnt by thymoquinone and other compounds can prevent cancer metastasis and chemoresistanceCC BY · PubMed Central
Fig. 5 The non-coding RNAs regulating Wnt/EMT axis in human cancers. The functional miRNAs present in the cytoplasm, while lncRNAs and circRNAs can be in cytoplasm or nucleus. Moreover, the inhibition of EMT by non-coding RNAs suppresses metastasis and EMT
Fig. 5 The non-coding RNAs regulating Wnt/EMT axis in human cancers. The functional miRNAs present in the cytoplasm, while lncRNAs and circRNAs can be in cytoplasm or nucleus. Moreover, the inhibition of EMT by non-coding RNAs suppresses metastasis and EMTCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

3 retracted

Show all 239 references

Cited by

See all 321

Metadata

Authors
Xue, W., Yang, L., Chen, C., Ashrafizadeh, M., Tian, Y., & Sun, R.
Affiliations
  • First Affiliated Hospital of Zhengzhou University (CN)
  • Xian Yang Central Hospital (CN)
  • Fudan University (CN)
  • Benedictine University (US)
Corresponding author
  • Ashrafizadeh, Milad
  • Tian, Yu
  • Sun, Ranran
Venue
Cellular and Molecular Life Sciences
Published
2024-02-09
Volume
81
Issue
1
Pages
79-79
ISSN
  • 1420-682X (ISSN-L)
  • 1420-9071
OpenAlex
W4391691695
Cited by
321
References
239
Citations by year
2026: 102 · 2025: 163 · 2024: 56
FWCI
13.09
Type
journal article
Language
en
Open access
Licence
Locations
  • Cellular and Molecular Life Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Young and Middle-aged Health Science and Technology Innovation Talents in 2020 (YXKC2020055)
  • Medical Science and Technology Project of Henan Province (SBGJ202002077)
  • Natural Science Foundation of Henan Province of China (202300410460)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
Wnt/β-catenin signaling, epithelial-mesenchymal transition, metastasis, drug resistance, GSK3β, Frizzled receptors, β-catenin nuclear translocation, non-coding RNA, phytochemicals, hematologic cancer, solid tumors
MeSH terms
Glycogen Synthase Kinase 3 beta, Cell Movement, Humans, Neoplasms, Gene Expression Regulation, Neoplastic, Cell Line, Tumor, beta Catenin, Epithelial-Mesenchymal Transition, Wnt Signaling Pathway

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Wnt/β-catenin-driven EMT regulation in human cancers. https://app.cochat.ai/papers/10.1007/s00018-023-05099-7
The paper
Xue, W., Yang, L., Chen, C., Ashrafizadeh, M., Tian, Y., & Sun, R. (2024). Wnt/β-catenin-driven EMT regulation in human cancers. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-023-05099-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.